neuron23.comHealthcareFounded: 2018Funding to Date: $213.61MM
Neuron23 develops precision medicines for genetically defined neurological and immunological diseases.
For more details on financing and valuation for Neuron23, register or login.
View Enterprise Value for Neuron23.
To read this article and more news on Neuron23, register or login.